Covid: Omicron surge could differ per country, says WHO

A top World Health Organisation official says low hospitalisation and death rates in South Africa due to the omicron variant cannot be considered a template for other countries

coronavirus testing
Photo: Bloomberg
AP | PTI Geneva
2 min read Last Updated : Jan 04 2022 | 8:57 PM IST

A top World Health Organisation official says low hospitalisation and death rates in South Africa due to the omicron variant cannot be considered a template for how the variant will fare as it surges in other countries.

Dr. Abdi Mahamud, COVID-19 incident manager at the U.N. health agency, notes a decoupling between case counts and deaths in the country, which first announced the emergence of the fast-spreading new variant.

He said Tuesday that in terms of hospitalisations South Africa remains "very low, and the death has remained very, very low.

But Mahamud says it cannot be extrapolated from South Africa to other countries, because each is country is unique on its own.

By its latest count, WHO says 128 countries had confirmed cases of the new variant that first emerged in southern Africa in November, but many other places which may not have complete testing capabilities are believed to have it too.

Mahamud notes that omicron has shown nearly unprecedented transmissibility for a virus.

He notes a remarkable increase in cases in the United States, where we are seeing more and more hospitalisations coming along. But he did cite an increasing number of studies showing omicron affects the upper part of the body, whereas other versions devastated lung function and caused severe pneumonia that led to many deaths.

Mahamud says that could be good news but that more studies are needed to get a full picture.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 04 2022 | 8:57 PM IST

Next Story